Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Abnormal Proliferation02:23

Abnormal Proliferation

4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
MicroRNAs01:22

MicroRNAs

3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Metastasis02:30

Metastasis

5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pyrolytic hydrocarbon growth from cyclopentadiene.

The journal of physical chemistry. A·2010
Same author

In(III)-catalyzed tandem reaction of chromone-derived Morita-Baylis-Hillman alcohols with amines.

Organic & biomolecular chemistry·2010
Same author

Regression-based multi-trait QTL mapping using a structural equation model.

Statistical applications in genetics and molecular biology·2010
Same author

Elevated expression of APE1/Ref-1 and its regulation on IL-6 and IL-8 in bone marrow stromal cells of multiple myeloma.

Clinical lymphoma, myeloma & leukemia·2010
Same author

Accelerated aging of intervertebral discs in a mouse model of progeria.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society·2010
Same author

The synthesis of a multiblock osteotropic polyrotaxane by copper(I)-catalyzed huisgen 1,3-dipolar cycloaddition.

Macromolecular bioscience·2010

Related Experiment Video

Updated: Jun 5, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.2K

m6A methylation modification: Potential pathways to suppress osteosarcoma metastasis.

Tianrui Hu1, Guowei Wang1, Dong Wang1

  • 1Department of Spine Surgery, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.

International Immunopharmacology
|December 11, 2024
PubMed
Summary

N-methylations (m6A) modification impacts osteosarcoma metastasis. Understanding m6A "writers," "erasers," and "readers" interactions can identify biomarkers and therapeutic targets for this aggressive bone cancer.

Keywords:
MethylationOsteosarcomaTumor metastasism6A

More Related Videos

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

9.0K
LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
12:18

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles

Published on: February 1, 2020

5.7K

Related Experiment Videos

Last Updated: Jun 5, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.2K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

9.0K
LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
12:18

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles

Published on: February 1, 2020

5.7K

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Osteosarcoma is an aggressive bone cancer with high metastasis rates, leading to poor patient prognosis.
  • Metastasis in osteosarcoma is a primary cause of treatment failure.
  • N-methylations (m6A) modification is increasingly recognized for its role in osteosarcoma progression.

Purpose of the Study:

  • To review the role of m6A methylation modification in osteosarcoma metastasis.
  • To elucidate the interactions between m6A regulators (writers, erasers, readers) and metastasis-related factors.
  • To identify potential diagnostic biomarkers and therapeutic targets for osteosarcoma metastasis.

Main Methods:

  • Literature review focusing on m6A methylation in osteosarcoma.
  • Analysis of interactions between m6A components and tumor metastasis pathways.
  • Synthesis of current research on m6A modification's impact on osteosarcoma invasion and metastasis.

Main Results:

  • m6A modification significantly influences osteosarcoma invasion and metastasis through various signaling pathways.
  • Specific "writers," "erasers," and "readers" of m6A methylation are implicated in the metastatic process.
  • Understanding these interactions provides insights into the mechanisms driving osteosarcoma spread.

Conclusions:

  • Clarifying the role of m6A methylation in osteosarcoma metastasis is crucial for improving patient outcomes.
  • m6A regulators represent promising targets for novel therapeutic strategies against osteosarcoma metastasis.
  • Further research into m6A modification could lead to the discovery of valuable clinical biomarkers.